Login Register Cart 0
Generic placeholder image

Current Bioactive Compounds

Editor-in-Chief

ISSN (Print): 1573-4072
ISSN (Online): 1875-6646

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Antihyperlipidemic and Antiobesity Potential of Aquilaria agallocha and Borago officinalis in Fixed-Dose Combination; A Contingent Probe with Atorvastatin and Orlistat

Author(s): Rohima Oraon, Tarique Ansari Mahmood*, Arshiya Shamim, Farogh Ahsan, Mohammad Shariq, Saba Parveen and Mehtab Alam

Volume 17, Issue 10, 2021

Published on: 01 March, 2021

Article ID: e190721191937 Pages: 13

DOI: 10.2174/1573407217666210302085822

Price: $65

Abstract

Aims: Antihyperlipidemic and antiobesity potential of a fixed dose combination of Aquilaria agallocha & Borago officinalis along with its comparative evaluation with Atorvastatin & Orlistat.

Background: Hyperlipidemia and obesity are common and challenging health problems throughout the world. These are the conditions in which increased lipids level in blood are the risk factors for atherosclerosis, coronary artery disease, and cerebral vascular diseases. In the present study, the fixed-dose combination of absolute ethanolic extract of Aquilaria agallocha and aqueous extract of Borago officinalis was examined for its antihyperlipidemic effect and antiobesity activity in the Sprague Dawley rats.

Objective: A suitable & established experimental model of hyperlipidemia and obesity based on literature survey has been selected. Comparative evaluation of fixed dose combination with selected standard drug against the established model. Compilation of results and statistical analysis.

Methods: Drugs and Chemicals: Atorvastatin solution, Orlistat solution, Formalin solution Animals: sprague dawley rats of 150-200 g of either sex were used for the study. Animals were habituated to laboratory conditions for 48 hours prior to experimental protocol to minimize if any of nonspecific stress. All the studies conducted were approve by the Institutional Animal Ethical Committee (IAEC) of Faculty of Pharmacy, Integral University Lucknow (Reg. no. 1213/PO/Re/S/08/CPCSEA, 5th June 2008) having approval no. IU/IAEC/18/32. High fat diet induced Dyslipidemia and obesity: Baseline characteristics of obesity and hyperlipedimia induced by high fat diet in Sprague dawley rats were maintained on normal pellet diet (NPD) for one week before the commencement of experiment. After one week rats were randomly assigned into normal and obese group and fed with NPD and High fat diet and libitum respectively for one week.The food intake, body weight gain ,and lipid profile were carried out on day 8 of dietary manipulation to assess the baseline characteristics of obesity and hyperlipidemia induced by high fat diet in Sprague dawley rats.

Results: The result of the study shows that the ethanolic extract of the FDC of aquilaria agallocha & borago officinalis has significant anti-hyperlipidemic and anti-obesity activity against High- fat diet-induced hyperlipidemia and obesity compared to atorvastatin (10 mg/kg) and orlistat (pure drug 10mg/kg).

Conclusion: The present study shows that pretreatment with ethanolic extract of FDC of Aquilaria agallocha & Borago officinalis significantly prevented from hyperlipidemia and obesity and decreased the levels of diagnostic marker enzymes significantly. At low dose (Borago officinalis 100 mg/kg + Aquilaria agallocha 250 mg/kg b.w.) ) ethanolic extract of FDC of Aquilaria agallocha & Borago officinalis showed moderate protection against Hyperlipidemia and Obesity. At high dose (Borago officinalis 200 mg/kg + Aquilaria agallocha 500 mg/kg b.w.) ethanolic extract of FDC of Aquilaria agallocha & Borago officinalis showed marked protection against High fat diet induced hyperlipidemia and obesity as well as by biochemical estimations of Lipid profile compare to the standard Atorvastatin(10mg/kg) and Orlistat(10mg/kg). Thus it concludes that ethanolic extract of FDC of Aquilaria agallocha & Borago officinalis possesses potent against high fat diet induced hyperlipidemia and obesity.

Keywords: Coronary artery disease, fixed-dose combination, hyperlipidemia, myocardial lipids, obesity, traditional medicine.

Graphical Abstract

[1]
Mollazadeh, H.; Mahdian, D.; Hosseinzadeh, H. Medicinal plants in treatment of hypertriglyceridemia: A review based on their mechanisms and effectiveness. Phytomedicine, 2019, 53, 43-52.
[http://dx.doi.org/10.1016/j.phymed.2018.09.024] [PMID: 30668411]
[2]
Menet, R.; Bernard, M.; ElAli, A. Hyperlipidemia in stroke pathobiology and therapy: Insights and perspectives. Front. Physiol., 2018, 9, 488.
[http://dx.doi.org/10.3389/fphys.2018.00488] [PMID: 29867540]
[3]
Expert AA. Secondary Hypertriglyceridemia., Available from:https://www.ncbi.nlm.nih.gov/books/NBK395574/
[4]
Furst, A. The Pharmacological Basis of Therapeutics, Ed. 4; Louis S., Goodman; Alfred, Gilman The Macmillan Company, Publishers: New York, 1970. MDMD 1794, $25.00.
[5]
Karam, I.; Yang, Y.J.; Li, J.Y. Hyperlipidemia background and progress. SM Atheroscler J., 2017, 1(1), 1003.
[6]
Smelt, A.H. Triglycerides and gallstone formation. Clin. Chim. Acta, 2010, 411(21-22), 1625-1631.
[http://dx.doi.org/10.1016/j.cca.2010.08.003] [PMID: 20699090]
[7]
Shattat, G.F. A review article on hyperlipidemia: types, treatments and new drug targets. Biomed. Pharmacol. J., 2015, 7(1), 399-409.
[8]
Vaseghi, G; Heshmat-Ghahdarijani, K; Shafiee, Z; Aliyari, R; Haghjooy-Javanmard, S; Hajian, S; Sarrafzadegan, N. Hematological Inflammatory Markers in patients with clinically confirmed familial hypercholesterolemia. Available from:https://www.researchsquare.com/article/rs-14667/v1
[9]
Indonesia, P.E. Konsensus pengelolaan dislipidemia di Indonesia; Pusat Penerbitan Ilmu Penyakit Dalam Fakultas Kedokteran UI: Jakarta, 2012.
[10]
Ginsberg, HN Disorders of lipoprotein metabolism. Harrison's principles of internal medicine., 2001, 2245-2257.
[11]
Tripathi, KD. Essentials of Medical Pharmacology; Jaypee Brothers Medical Publishers: New Delhi, 2013, p. 30.
[12]
Joseph, D. Pharmacotherapy A Pathophysiological Approach, 8th edn; The McGraw Hill companies, Inc, 2011, p. 370.
[13]
Mozaffarian, D.; Benjamin, E.J.; Moy, C.S.; Muntner, P. Mussolino, M.E.; Nasir, K.; Neumar, R.W.; Nichol, G.; Palaniappan, L.; Pandey, D.K.; Reeves, M.J.; Rodriguez, C.J.; Sorlie, P.D.; Stein, J.; Towfighi, A.; Turan, T.N.; Virani, S.S.; Willey, J.Z.; Woo, D.; Yeh, R.W.; Turner, M.B. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation, 2015, 131(4), e29-322.
[14]
Karr, S.; Gurney, M.K.; Early, N.K. Accuracy of community-based blood pressure devices versus validated self-use devices. J. Am. Pharm. Assoc. (2003), 2015, 55(4), 419-423.
[http://dx.doi.org/10.1331/JAPhA.2015.14146] [PMID: 26161483]
[15]
Stone, N.J.; Robinson, J.G.; Lichtenstein, A.H.; Bairey Merz, C.N.; Blum, C.B.; Eckel, R.H.; Goldberg, A.C.; Gordon, D.; Levy, D.; Lloyd-Jones, D.M.; McBride, P.; Schwartz, J.S.; Shero, S.T.; Smith, S.C., Jr; Watson, K.; Wilson, P.W.; Eddleman, K.M.; Jarrett, N.M.; LaBresh, K.; Nevo, L.; Wnek, J.; Anderson, J.L.; Halperin, J.L.; Albert, N.M.; Bozkurt, B.; Brindis, R.G.; Curtis, L.H.; DeMets, D.; Hochman, J.S.; Kovacs, R.J.; Ohman, E.M.; Pressler, S.J.; Sellke, F.W.; Shen, W.K.; Smith, S.C., Jr; Tomaselli, G.F. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2014, 129(25)(Suppl. 2), S1-S45.
[http://dx.doi.org/10.1161/01.cir.0000437738.63853.7a] [PMID: 24222016]
[16]
Newman-Casey, P.A.; Talwar, N.; Nan, B.; Musch, D.C.; Stein, J.D. The relationship between components of metabolic syndrome and open-angle glaucoma. Ophthalmology, 2011, 118(7), 1318-1326.
[http://dx.doi.org/10.1016/j.ophtha.2010.11.022] [PMID: 21481477]
[17]
Wang, S.; Bao, X. Hyperlipidemia, blood lipid level, and the risk of glaucoma: A meta-analysis. Invest. Ophthalmol. Vis. Sci., 2019, 60(4), 1028-1043.
[http://dx.doi.org/10.1167/iovs.18-25845] [PMID: 30897618]
[18]
Economos, CD; Folta, SC; Goldberg, J; Hudson, D; Collins, J; Baker, Z; Lawson, E; Nelson, M A community-based restaurant initiative to increase availability of healthy menu options in Somerville, Massachusetts: Shape up Somerville. Prev. Chronic Dis., 2009, 6(3), A102.
[19]
Ofei, F. Obesity - A preventable disease. Ghana Med. J., 2005, 39(3), 98-101.
[PMID: 17299552]
[20]
Kissebah, A.H.; Krakower, G.R. Regional adiposity and morbidity. Physiol. Rev., 1994, 74(4), 761-811.
[http://dx.doi.org/10.1152/physrev.1994.74.4.761] [PMID: 7938225]
[21]
Caballero, B. The global epidemic of obesity: an overview. Epidemiol. Rev., 2007, 29(1), 1-5.
[http://dx.doi.org/10.1093/epirev/mxm012] [PMID: 17569676]
[22]
Van Itallie, TB Health implications of overweight and obesity in the United States. Ann Intern Med., 1985, 103(6-2), 983-988..
[http://dx.doi.org/10.7326/0003-4819-103-6-983]
[23]
Alam, J.; Mujahid, M.; Rahman, M.; Akhtar, J.; Khalid, M.; Jahan, Y.; Basit, A.; Khan, A.; Shawwal, M.; Iqbal, S.S. An insight of pharmacognostic study and phytopharmacology of Aquilaria agallocha. J. Appl. Pharm. Sci., 2015, 5(8), 173-181.
[http://dx.doi.org/10.7324/JAPS.2015.50827]
[24]
Duke, J.A. Handbook of phytochemical constituent grass, herbs and other economic plants; CRC press, 1992.
[25]
STANISCI, A.; Acosta, A.; Ercole, S Plant communities on coastal dunes in Lazio (Italy). Ann. Bot., 2004, 4, 115-128.
[26]
Hayder, M.A.; Rahman, L.M.; Rahman, M.A. Experimental agar production project; Department of Forests, Ministry of Environment and Forest: Dhaka, 2005, pp. 1-6.
[27]
Rahman, M.A.; Khisa, S.K. Agar production in agar tree by artificial inoculation and wounding. II. Further evidences in favour of agar formation. Bano Biggyan Patrika, 1984, 13(1/2), 57-63.
[28]
Zhang, X.L.; Liu, Y.Y.; Wei, J.H.; Yang, Y.; Zhang, Z.; Huang, J.Q.; Chen, H.Q.; Liu, Y.J. Production of high-quality agarwood in Aquilaria sinensis trees via whole-tree agarwood-induction technology. Chin. Chem. Lett., 2012, 23(6), 727-730.
[http://dx.doi.org/10.1016/j.cclet.2012.04.019]
[29]
Liu, CM; Perng, MH; Chen, CY The antioxidation and antiproliferation activity of flavonoids from Aquilaria agallocha and Aquilaria sinensis. Biomed. Res., 2018, 29(10), 2191-2196.
[30]
Yagura, T.; Shibayama, N.; Ito, M.; Kiuchi, F.; Honda, G. Three novel diepoxy tetrahydrochromones from agarwood artificially produced by intentional wounding. Tetrahedron Lett., 2005, 46(25), 4395-4398.
[http://dx.doi.org/10.1016/j.tetlet.2005.04.072]
[31]
Alla, T.; Handral, M.; Nandakumar, K.; Venkatrao, N.; Shantakumar, S.M. Anxiolytic and anticonvulsant activity of alcoholic extract of heartwood of Aquilaria agallocha roxb,(Thymelaeceae) in mice. Pharmacologyonline, 2007, 1, 564-572.
[32]
Miles, AM; Grisham, MB. Antioxidant properties of aminosalicylates In: Methods in enzymology; , 1994; Vol. 234, pp. 555-572.
[33]
Sharma, O.P.; Bhat, T.K. DPPH antioxidant assay revisited. Food Chem., 2009, 113(4), 1202-1205.
[http://dx.doi.org/10.1016/j.foodchem.2008.08.008]
[34]
Miniyar, P.B.; Chitre, T.S.; Deuskar, H.J.; Karve, S.S.; Jain, K.S. Antioxidant activity of ethyl acetate extract of Aquilaria agallocha on nitrite-induced methaemoglobin formation P. Int. J. Green Pharm., 2008, 2(2)
[http://dx.doi.org/10.4103/0973-8258.41185]
[35]
Omar, N.A.; Zulkifle, N.L.; Tajudin, S.N. Antidiabetic activities of Malaysian Agarwood leaves extract. In Conference on industry Academia Joint Initiatives in Biotechnology CIA, 2013, Vol. 5, 7.
[36]
Pranakhon, R.; Pannangpetch, P.; Aromdee, C. Antihyperglycemic activity of agarwood leaf extracts in STZ-induced diabetic rats and glucose uptake enhancement activity in rat adipocytes. Songklanakarin J. Sci. Technol., 2011, 33(4)
[37]
Hara, H.; Ise, Y.; Morimoto, N.; Shimazawa, M.; Ichihashi, K.; Ohyama, M.; Iinuma, M. Laxative effect of agarwood leaves and its mechanism. Biosci. Biotechnol. Biochem., 2008, 72(2), 335-345.
[http://dx.doi.org/10.1271/bbb.70361] [PMID: 18256503]
[38]
Takemoto, H.; Ito, M.; Shiraki, T.; Yagura, T.; Honda, G. Sedative effects of vapor inhalation of agarwood oil and spikenard extract and identification of their active components. J. Nat. Med., 2008, 62(1), 41-46.
[http://dx.doi.org/10.1007/s11418-007-0177-0] [PMID: 18404340]
[39]
Vakati, K.; Rahman, H.; Eswaraiah, M.C.; Dutta, A.M. Evaluation of hepatoprotective activity of ethanolic extract of Aquilaria agallocha leaves (EEAA) against CCl4 Induced Hepatic Damage in Rat. Sch J App Med Sci, 2013, 1(1), 9-12.
[40]
Iyer, S.R. Indian Medicinal Plants, A compendium of 500species. Hyderabad, India: Orient Longman. Int. J. Basic. Med. Sci. Pharm., 2012, 2, 2049-2063.
[41]
Suebsasana, S.; Pongnaratorn, P.; Sattayasai, J.; Arkaravichien, T.; Tiamkao, S.; Aromdee, C. Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals. Arch. Pharm. Res., 2009, 32(9), 1191-1200.
[http://dx.doi.org/10.1007/s12272-009-1902-x] [PMID: 19784573]
[42]
Rahman, H.; Vakati, K.; Eswaraiah, M.C. In-vivo and in-vitro anti-inflammatory activity of Aquilaria agallocha oil. Int. J. Basic Med. Sci. Pharm., 2012, 2(1), 7-10.
[43]
Winter, C.A.; Porter, C.C. Journal of the American Pharmaceutical Association. Effect of alterations in side chain upon anti-inflammatory and liver glycogen activities of hydrocortisone esters. J. Am. Pharm. Assoc. Am. Pharm. Assoc., 1957, 46(9), 515-519.
[http://dx.doi.org/10.1002/jps.3030460902] [PMID: 13491439]
[44]
Dash, M.; Patra, J.K.; Panda, P.P. Phytochemical and antimicrobial screening of extracts of Aquilaria agallocha Roxb. Afr. J. Biotechnol., 2008, 7(20)
[45]
D’amour, F.E.; Smith, D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther., 1941, 72(1), 74-79.
[46]
Khalil, A.S.; Rahim, A.A.; Taha, K.K.; Abdallah, K.B. Characterization of methanolic extracts of agarwood leaves. J. Appl. Indust. Sci., 2013, 1(3), 78-88.
[47]
Chitre, T.; Bhutada, P.; Nandakumar, K.; Somani, R.; Miniyar, P.; Mundhada, Y.; Gore, S.; Jain, K. Analgesic and anti-inflammatory activity of heartwood of Aquilaria agallocha in laboratory animals. Pharmacol. Online, 2007, 1, 288-298.
[48]
Hunskaar, S.; Hole, K. The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain. Pain, 1987, 30(1), 103-114.
[http://dx.doi.org/10.1016/0304-3959(87)90088-1] [PMID: 3614974]
[49]
Gorski, F.; Corrêa, C.R.; Filho, V.C.; Yunes, R.A.; Calixto, J.B. Potent antinociceptive activity of a hydroalcoholic extract of Phyllanthus corcovadensis. J. Pharm. Pharmacol., 1993, 45(12), 1046-1049.
[http://dx.doi.org/10.1111/j.2042-7158.1993.tb07178.x] [PMID: 7512649]
[50]
Okugawa, H.; Ueda, R.; Matsumoto, K.; Kawanishi, K.; Kato, A. Effects of agarwood extracts on the central nervous system in mice. Planta Med., 1993, 59(1), 32-36.
[http://dx.doi.org/10.1055/s-2006-959599] [PMID: 8441779]
[51]
Kim, Y.C.; Lee, E.H.; Lee, Y.M.; Kim, H.K.; Song, B.K.; Lee, E.J.; Kim, H.M. Effect of the aqueous extract of Aquilaria agallocha stems on the immediate hypersensitivity reactions. J. Ethnopharmacol., 1997, 58(1), 31-38.
[http://dx.doi.org/10.1016/S0378-8741(97)00075-5] [PMID: 9324002]
[52]
Vacillotto, G.; Favretto, D.; Seraglia, R.; Pagiotti, R.; Traldi, P.; Mattoli, L. A rapid and highly specific method to evaluate the presence of pyrrolizidine alkaloids in Borago officinalis seed oil. J. Mass Spectrom., 2013, 48(10), 1078-1082.
[http://dx.doi.org/10.1002/jms.3251] [PMID: 24130010]
[53]
Akbar, S. Handbook of 200 Medicinal Plants: A Comprehensive Review of Their Traditional Medical Uses and Scientific Justifications.Springer Nature, 2020.
[http://dx.doi.org/10.1007/978-3-030-16807-0]
[54]
Unani Pharmacopeia of India, part-1 2009, vol-2
[55]
Life Seasons, Inc. 940 S 2000 W Suite 230. Available from:https://lifeseasons.com/gaozaban
[56]
BORAGE. Available from:https://www.phytomania.com/english/borage.htm
[57]
Hamed, A.N.; Wahid, A. Hepatoprotective activity of Borago officinalis extract against CCl4-induced hepatotoxicity in rats. J. Nat. Prod., 2015, 8, 113-122.
[58]
Al-janabi, M.S.; Ahmed, M.S. The effect of aqueous extract of Borago officinalis and uranyl acetate on lipid profile and in Albino males rabbits exposed to oxidative stress. Tikrit Med. J., 2015, 20(2), 97-107.
[59]
Gu, J.Y.; Wakizono, Y.; Dohi, A.; Nonaka, M.; Sugano, M.; Yamada, K. Effect of dietary fats and sesamin on the lipid metabolism and immune function of Sprague-Dawley rats. Biosci. Biotechnol. Biochem., 1998, 62(10), 1917-1924.
[http://dx.doi.org/10.1271/bbb.62.1917] [PMID: 9836427]
[60]
Ghahremanitamadon, F.; Shahidi, S.; Zargooshnia, S.; Nikkhah, A.; Ranjbar, A.; Soleimani Asl, S. Protective effects of Borago officinalis extract on amyloid β-peptide(25-35)-induced memory impairment in male rats: A behavioral study. BioMed Res. Int., 2014, 2014, 798535.
[http://dx.doi.org/10.1155/2014/798535] [PMID: 25013802]
[61]
Asadi-Samani, M.; Bahmani, M.; Rafieian-Kopaei, M. The chemical composition, botanical characteristic and biological activities of Borago officinalis: A review. Asian Pac. J. Trop. Med., 2014, 7S1, S22-S28.
[http://dx.doi.org/10.1016/S1995-7645(14)60199-1] [PMID: 25312125]
[62]
Shahraki, M.R.; Ahmadimoghadm, M.; Shahraki, A.R. The antinociceptive effects of hydroalcoholic extract of Borago officinalis flower in male rats using formalin test. Basic Clin. Neurosci., 2015, 6(4), 285-290.
[PMID: 26649166]
[63]
Mhamdi, B.; Wannes, W.A.; Sriti, J.; Jellali, I.; Ksouri, R.; Marzouk, B. Effect of harvesting time on phenolic compounds and antiradical scavenging activity of Borago officinalis seed extracts. Ind. Crops Prod., 2010, 31(1), e1-e4.
[http://dx.doi.org/10.1016/j.indcrop.2009.07.002]
[64]
Aliakbarlu, J.; Tajik, H. Antioxidant and antibacterial activities of various extracts of Borago officinalis flowers. J. Food Process. Preserv., 2012, 36(6), 539-544.
[http://dx.doi.org/10.1111/j.1745-4549.2011.00622.x]
[65]
Ciriano, M.G.; García-Herreros, C.; Larequi, E.; Valencia, I.; Ansorena, D.; Astiasarán, I. Use of natural antioxidants from lyophilized water extracts of Borago officinalis in dry fermented sausages enriched in ω-3 PUFA. Meat Sci., 2009, 83(2), 271-277.
[http://dx.doi.org/10.1016/j.meatsci.2009.05.009] [PMID: 20416739]
[66]
Cameron, M; Gagnier, JJ; Chrubasik, S Herbal therapy for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews., 2011, 2
[http://dx.doi.org/10.1002/14651858.CD002948.pub2]
[67]
Engler, M.M.; Engler, M.B. Dietary borage oil alters plasma, hepatic and vascular tissue fatty acid composition in spontaneously hypertensive rats. Prostaglandins Leukot. Essent. Fatty Acids, 1998, 59(1), 11-15.
[http://dx.doi.org/10.1016/S0952-3278(98)90046-1] [PMID: 9758202]
[68]
Engler, M.M.; Schambelan, M.; Engler, M.B.; Ball, D.L.; Goodfriend, T.L. Effects of dietary γ-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats. Proc. Soc. Exp. Biol. Med., 1998, 218(3), 234-237.
[http://dx.doi.org/10.3181/00379727-218-44292] [PMID: 9648942]
[69]
Mills, D.E.; Prkachin, K.M.; Harvey, K.A.; Ward, R.P. Dietary fatty acid supplementation alters stress reactivity and performance in man. J. Hum. Hypertens., 1989, 3(2), 111-116.
[PMID: 2760908]
[70]
Harbige, L.S.; Layward, L.; Morris-Downes, M.M.; Dumonde, D.C.; Amor, S. The protective effects of omega-6 fatty acids in Experimental Autoimmune Encephalomyelitis (EAE) in relation to Transforming Growth Factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin. Exp. Immunol., 2000, 122(3), 445-452.
[http://dx.doi.org/10.1046/j.1365-2249.2000.01399.x] [PMID: 11122253]
[71]
Gilani, A.H.; Bashir, S.; Khan, A.U. Pharmacological basis for the use of Borago officinalis in gastrointestinal, respiratory and cardiovascular disorders. J. Ethnopharmacol., 2007, 114(3), 393-399.
[http://dx.doi.org/10.1016/j.jep.2007.08.032] [PMID: 17900837]
[72]
Tollesson, A.; Frithz, A. Borage oil, an effective new treatment for infantile seborrhoeic dermatitis. Br. J. Dermatol., 1993, 129(1), 95.
[http://dx.doi.org/10.1111/j.1365-2133.1993.tb03322.x] [PMID: 8396411]
[73]
Bandoniene, D.; Murkovic, M. The detection of radical scavenging compounds in crude extract of borage (Borago officinalis L.) by using an on-line HPLC-DPPH method. J. Biochem. Biophys. Methods, 2002, 53(1-3), 45-49.
[http://dx.doi.org/10.1016/S0165-022X(02)00091-X] [PMID: 12406585]
[74]
Lin, L.T.; Liu, L.T.; Chiang, L.C.; Lin, C.C. In vitro anti-hepatoma activity of fifteen natural medicines from Canada. Phytother. Res., 2002, 16(5), 440-444.
[http://dx.doi.org/10.1002/ptr.937] [PMID: 12203264]
[75]
Komaki, A.; Rasouli, B.; Shahidi, S. Anxiolytic effect of borago officinalis (boraginaceae) extract in male rats. Avicenna J. Neuropsychophysiol., 2015, 2(1), 34-38.
[http://dx.doi.org/10.17795/ajnpp-27189]
[76]
Vijaya, C; Ramanathan, M; Suresh, B Lipid lowering activity of ethanolic extract of leaves of Aegle marmelos (Linn.) in hyperlipidaemic models of Wistar albino rats. Indian J. Exp. Biol., 2009, 47(3), 182-185.
[77]
Firoz, M.; Bharatesh, K.; Nilesh, P.; Vijay, G.; Tabassum, S.; Nilofar, N. Cardioprotective activity of ethanolic extract of Callistemon lanceolatus leaves on doxorubicin-induced cardiomyopathy in rats. Bangladesh J. Pharmacol., 2011, 6(1), 38-45.
[http://dx.doi.org/10.3329/bjp.v6i1.8154]

Rights & Permissions Print Cite
Article Metrics
8
1
© 2024 Bentham Science Publishers | Privacy Policy